-
Control Algorithm Developed to Fly Robot Aircraft Indoors
Aeronautical and computer engineers at Massachusetts Institute of Technology built and tested an autonomously driven fixed-wing model aircraft guided by algorithms that let it navigate a complex indoor flight space. The team from MIT’s Robust Robotics Group describe their invention in a paper presented in May at the IEEE International Conference on Robotics and Automation.…
-
Technology Developed for Mass Wireless Chip Printing
Engineers in Korea developed a process for printing cheap electronic devices on every day items that can transmit data to smartphones. The work of the authors from Sunchon National University and Paru Printed Electronics Research Institute is described in the journal Nanotechnology (free registration required), published by Institute of Physics. The team led by Jinsoo…
-
Pfizer, Biotech to Partner on Autoimmune Disorders
The global pharmaceutical company Pfizer Inc. and biotechnology company Nodality Inc. in South San Francisco, California agreed to a partnership that provides Pfizer with access to Nodality’s cell signaling analysis technology to streamline development of treatments for autoimmune diseases, beginning with lupus. The financial amount of the multi-year year was not disclosed. Nodality has created…
-
Renewable Power Storage, Management Modules in Development
Systems that integrate renewable power sources with battery storage and management modules are being developed for pilot testing at Karlsruhe Institute of Technology in Germany. The first of the modular systems, with a 50 kilowatt capacity, will be constructed on the Karlsruhe campus by the end of the year. The modular energy systems are being…
-
Trial Shows Generic Vaccine Helps Reverse Type 1 Diabetes
An early clinical trial indicates a generic vaccine that raises levels of an immune system modulator can kill autoimmune cells targeting the pancreas and temporarily restore insulin secretion in type 1 diabetes patients. Findings from the trial, conducted by researchers at Massachusetts General Hospital and Harvard Medical School in Boston, appear in the online journal…
-
UC San Diego, Yale to Build Neuroscience Gateway
University of California in San Diego and Yale University are developing an online gateway to provide high-performance computational tools for neuroscientists. The Neuroscience Gateway project is funded by a three year, $707,000 grant from National Science Foundation. UC San Diego will make available its supercomputer center and Neuroscience Information Framework for neuroscientists to access advanced…
-
NSF Grant to Fund R&D on Wireless Network Chip Connections
Engineers at Drexel University in Philadelphia are developing semiconductors using wireless connections in a network to exchange data among the chip’s components. The project is funded by a three-year $400,000 grant from National Science Foundation’s Electrical, Communications, and Cyber Systems division. The research is led by electrical engineering professor Baris Taskin (pictured left), who directs…
-
Biotech Begins Clinical Trial for Stroke Treatment
ZZ Biotech, a biotechnology company in Houston, began a clinical trial of an experimental drug to treat acute ischemic stroke, where blood flow to the brain is blocked by a clot. The drug being tested is 3K3A-APC, the result of research first conducted at University of Southern California and Scripps Research Institute in California, and…
-
Color Codes, Eye-Level Positions Boost Healthy Food Choices
A hospital’s program encouraging more healthful cafeteria food choices through color-coded labels and the positioning of items in display cases was found successful across all categories of employees. A team from Massachusetts General Hospital in Boston, led by Harvard University public health professor Douglas Levy, published a study of the program online in the American…
-
Targeted Cancer Therapies Result in Fewer Side Effects
An analysis of data from early-phase clinical trials indicates patients treated with targeted cancer therapies have a lower risk of more serious side effects than with traditional chemotherapy. The findings from researchers at the Institute of Cancer Research in London, U.K., and Royal Marsden NHS Foundation Trust appear in this month’s issue of the journal…